Assessment and Tracking of Long-term Alefacept Safety

Stopped early

Conditions studied: Psoriasis

In brief

Subjects exposed to alefacept are to be enrolled. Subjects will be contacted every 6 months to gather general health information.

Key facts

Study ID
NCT00454701
Run by
Astellas Pharma Inc
People needed
1897
Starts
2003-06-01
Expected to finish
2012-02-01
Last updated by the study team
2013-12-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.